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Abstract 23 
Atlantic salmon post-smolts of an average of 940g were fed six diets including two marine 24 
based commercial diets one with partial inclusion of vegetable proteins (VPs) and oils (VOs) 25 
(2011/12 EU standards) (MB) and a second with partial inclusion of VPs, land animal-by 26 
product (ABP) proteins and VOs (non-EU standards) (MBABP), a fully vegetable protein (VP) 27 
diet; a fully algal and VOs (VO) diet; a fishery-free vegetable-based (VP/VO) diet; and a 28 
fishery-free diet with a mix of VPs and ABP proteins and a mix of algal and vegetable oils 29 
(MFABP). Growth was assessed at Days 104 and 175, whereas fillet proximate composition, 30 
haematology and innate immune responses were assessed upon termination. Overall, MB 31 
salmon was the best performing group for the full period in terms of feed intake and overall 32 
weight gain. MB and VP salmon exhibited the highest FCRs compared to the other groups, 33 
while VP salmon exhibited the highest condition factor (K) and VO salmon the lowest K 34 
compared to the other groups. Fillet proximate composition did not present differences among 35 
the 6 groups. MB salmon demonstrated the highest plasma lysozyme activity compared to the 36 
other groups while MFABP, VP and VP/VO salmon demonstrated higher plasma anti-protease 37 
activity in contrast to MB salmon. The dietary groups did not present differences in plasma 38 
protein, total IgM or natural haemolytic activity while unaltered head kidney macrophage 39 
respiratory burst activity was also observed. Overall, diets free from marine proteins or oils 40 
and/or both were satisfactorily utilised by salmon without compromising their immune 41 
capacity, although longer adaptation periods are required. 42 
1. Introduction 43 
The stagnating supplies of marine proteins and oils from wild fisheries, have led the aquafeed 44 
sector to seek for alternative protein and lipid sources. Numerous alternatives to fishmeals 45 
(FMs) and fish oils (FOs) are available from other sources, mainly grains, oilseeds, material 46 
recovered from the processing of terrestrial livestock and unicellular organisms (yeasts, 47 
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moulds, bacteria and microalgae). The use of plant derived feedstuffs as sustainable 48 
alternatives to marine meals and oils in Atlantic salmon feeds however, has been the main focus 49 
of salmon nutrition, as these ingredients have high global availability at competitive prices in 50 
comparison to FM and FO, and premium nutritional properties for most farmed salmonids.  On 51 
the contrary, the use of terrestrial animal by-products (ABPs), although of great potential has 52 
not yet been explored to a similar extend in salmon diets, despite the fact that they have been 53 
used in many salmon producing countries including Australia, Canada and Chile. The main 54 
reason for that were the legal restrictions established by the European Union (EU), regarding 55 
the use of the greater majority of animal derived products, aiming the eradication of 56 
transmissible spongiform encephalopathies (TSE) (EU 2001, 2003). However, the rules 57 
regarding the use of non-ruminant ABPs such as poultry, feather and porcine blood meals in 58 
commercial aquafeeds have been revoked for the past few years (van Dyck 2012).  59 
Vegetable proteins in aquafeeds should be low in oligo- and poly-saccharides, largely 60 
free from antinutritional factors (ANFs), have a high protein content, favourable amino acid 61 
profile, high nutrient digestibility and be acceptable by the fish (Naylor et al. 2009). Plant 62 
protein concentrates, wheat and corn gluten meals possess most of these characteristics (Naylor 63 
et al. 2009). On the contrary, ABPs are free from ANFs and therefore their application in 64 
salmon feeds could be more desirable compared to their plant protein counterparts. As yet, 65 
several studies on various salmonids have assessed the potential of some of these ABPs with 66 
promising results (Higgs et al. 1979; Steffens 1994; Twibell et al. 2012; Hatlen et al. 2014). 67 
Moreover, it has been proven that close to 100% dietary FM replacement with premium plant 68 
and animal-proteins is possible for Atlantic salmon, with no negative effects on growth and 69 
feed intake when the dietary amino acid profile is well balanced (Espe et al. 2006; Torstensen 70 
et al. 2008). While studies have investigated the effects of moderate FM substitution with plant 71 
feedstuffs on Atlantic salmon immune responses (Krogdahl et al. 2000; Bransden et al. 2001) 72 
4 
 
the current knowledge about the effects of complete FM replacement on these is unexplored. 73 
Studies on partial FM replacement however, demonstrated that moderate levels of dietary SPC 74 
in salmon diets promoted gut immune responses such as lysozyme and total IgM levels and 75 
resistance to Aeromonas salmonicida (Krogdahl et al. 2000). Moreover, Bransden et al. (2001) 76 
showed that partial FM substitution with dehulled lupin meal (DLM) or a blend of DLM with 77 
hydrolysed poultry feather meal (HPFM) in Atlantic salmon diets does not compromise salmon 78 
growth, immune responses or resistance to Vibrio anguillarum.  79 
Similarly to FM, several studies have revealed that  FO can be completely substituted 80 
by selected single or mixed VOs in Atlantic salmon diets (Bell et al. 2001, 2002; Torstensen et 81 
al. 2005, 2008). In the present trial, diets with complete replacement of FO were supplemented 82 
with algal oil as a source of n-3 PUFAs while the n-6/n-3 C20 PUFA ratio was kept relatively 83 
constant (~1) among FO and FO-free diets. Carter et al. (2003) reported no changes on the 84 
growth performance of Atlantic salmon fed on diets containing a mixture of canola oil (CO) 85 
and FO or CO and algal (traustochytrids) oil. While, studies on partial or complete replacement 86 
of either FM or FO in salmon diets have been widely undertaken, the impact of a combined 87 
complete replacement of both, on salmon growth performance and immune responses has not 88 
yet been investigated.  89 
Currently FM inclusion in commercial salmon diets range from 15% to 55% while FO 90 
levels range from 3% to 40%. These variations largely depend on the country feeds are 91 
manufactured, and partially reflect differences in the employed production systems, local 92 
regulations or legal restrictions as well as differences among the farmed salmon breeds 93 
(DeSilva et al. 2012). The present study focused on the innate immune responses and 94 
performance of Atlantic salmon post-smolts, fed on two commercial FM- and FO-based feeds, 95 
combined with either blends vegetal proteins and oils solely, or a mix of vegetal and ABP 96 
proteins with VOs, and fish fed on fully VP or VO and algal oil diets or two feeds with complete 97 
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FM and FO substitution with vegetal products (VPs, VOs and algal oils) or a combination of 98 
the above with ABPs, was compared.  For the present trial, the FM used was tested against 99 
many other FM sources and was found to be consistently the highest performing source, while 100 
protein and lipid sources utilised in the present trial were selected based on their premium 101 
quality.  102 
2. Materials and Methods 103 
2.1. Diets and growth trial 104 
Six different feeds with different levels of FM and FO substitution (Table 1) were tested for 105 
their effects on growth performance and health status of Atlantic salmon post-smolts. Two 106 
commercial FM and FO based EWOS diets, the first with partial inclusion of vegetable protein 107 
concentrates and oils according to the EU standards of 2011-12, namely European marine 108 
based (MB) diet, and a second with partial addition of a mixture of VPCs, land ABP proteins 109 
and VOs according to non-EU standards, denoted as marine based with inclusion animal by-110 
products diet (MBABP), were used as control treatments. In the VP diet the FM was completely 111 
substituted by VPCs, while complete replacement of FO by VOs and algal lipids (the latter 112 
used as a source of long chain n-3 PUFAs) was applied in VO diet. Higher levels of FO were 113 
included in the VP-based diets in order to compensate for the residual amounts of lipid found 114 
in FM. Complete substitution of marine proteins and lipids was tested using two different diets, 115 
a fully vegetarian one with complete replacement of FM and FO with VPCs and a combination 116 
of VOs and algal oils denoted as VP/VO diet and a second one combining also the inclusion of 117 
land animal by-product proteins (poultry and porcine blood meal) namely MFABP diet. The 118 
raw materials used to replace FM, as well as the FM itself, were previously included in a routine 119 
program to measure protein digestibility and were selected for use in the study due to their high 120 
scores on this quality aspect (Crampton, personal communication). Diets with partial or total 121 
substitution of FM with alternative protein sources were supplemented with synthetic amino 122 
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acids and premixes with a starch binder in order to balance nutrients. All diets were formulated 123 
to meet the nutrient requirements of salmon according to NRC (1993). Diets were pelleted 124 
through extrusion (EWOS Innovation, Dirdal, Norway).  125 
 Growth trials were conducted at EWOS Innovation facilities at Dirdal, Norway. 126 
Unvaccinated Atlantic salmon post-smolts (S0 smolts) of 550g mean body weight, from a 127 
commercial SalmoBreed AS (Bergen, Norway) strain selected for improved growth 128 
performance were allocated in 24 seawater supplied tanks, until a total of 55 fish were in each 129 
tank. Fish were acclimatised to the experimental tanks for 84 days prior to the start of the 130 
experiment due to technical issues (delays in the delivery of some of the raw materials used in 131 
the experimental feed formulations and thus the manufacturing of the trial feeds), during which 132 
time they were fed a commercial diet (EWOS OPAL 500) and later allocated their experimental 133 
diet. Daily feeding throughout this period was based on appetite control. Uneaten pellets during 134 
this time were counted every day. The system consisted of cylindrical fibreglass tanks with a 135 
water volume of 3.0 m3. Each tank was supplied by running seawater pumped from the nearby 136 
fjord at 50m depth (salinity range of 29 ± 1.3 g × l-1 and temperature ranging from 6.3 ºC in 137 
March (lowest temperature recorded) to 9.1 ºC in August (25th) (highest temperature recorded) 138 
(Average water temperature 7.7 ± 1.4 ºC) at a flow rate of 0.8 l × kg × biomass-1× min-1.  139 
 A continuous lighting regime was used during the acclimation and feeding trial period. 140 
For the feeding trial, quadruplicate tanks of fish were provided one of the 6 experimental 141 
treatments. The fish were weighed prior to the acclimation period (16th of December 2010), at 142 
the start of the trial (day 0) (10th of March 2011), at days 104-105 (22nd and 23rd of June 2011) 143 
and at the end of the study (days 175-176) (2nd and 3rd of September 2011). The average weight 144 
of salmon at the start of the feeding trial was approximately 940g. During the feeding trial 145 
period, fish were given pellets of 5mm. Two different dietary batches were used for the full 146 
duration of the study. The first batch was given to the fish during the first period of the study 147 
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from the 10th of March until the 21st of June whereas the second lot was used for the second 148 
part of the trial from the 24th of June until the 31st of August. Fish were fed four times daily 149 
(feeding times: 01:00, 07:00, 19:00, and 22:00) using an automatic feeding system (Exact; 150 
Storvik Aqua, SV, Sundalsøra, Norway). The daily amount of feed was equally distributed 151 
within these four feed intervals. Feeding period for each feed interval was about 30-60 min 152 
depending on the total feed amount per day. Feed doses were delivered every 60 sec to the 153 
tanks for each feeding period whilst the total amount of feed delivered at each feeding time of 154 
the feeding period was 3-7 g. The specific feeding rate was the same for acclimation and trial 155 
period. The level of daily feed ratio was about 0.5-1.5 of total biomass. To ensure that all fish 156 
(or at least as many fish as possible) received adequate feed each day, the daily feed ration was 157 
adjusted accordingly so that the amount of uneaten feed laid between 15-30% of the total feed 158 
amount offered. An average of 25% "overfeeding" was obtained for the full trial period. 159 
Uneaten feed was collected using waste feed collectors. Therefore, estimates of the actual feed 160 
consumption and thereby FCRs were possible. The growth trial was conducted for a total of 161 
196 days, at which time all fish were removed from the tanks and weighed twice (days 125-162 
126 and days 194-197) after being anaesthetised (MS222,  2g × l-1). On days 125-126 twenty 163 
fish from each tank were euthanised with an overdose of  MS222 (7 g × l-1) to keep biomass 164 
densities below 90 kg × m-3 in the tanks resulting in a final number of 35 fish × tank-1 (starting 165 
mean biomass density of 52 kg × m-3 (55 post-smolts); intermediate mean biomass density of 166 
67 kg × m-3 after the removal of 20 salmon (35 salmon); final mean biomass density of 87 kg 167 
× m-3 (35 salmon)). 168 
2.2. Sample collection 169 
For immunological analyses, blood was withdrawn from the caudal vein of 6 ﬁsh from each 170 
tank, on days 194 and 195 from start of the experiment, using 1 ml syringes rinsed with heparin 171 
(10 IU × ml-1); Sigma-Aldrich, Dorset, UK) while pools of Norwegian quality cut (NQC) fillet 172 
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samples from 4 fish per tank were obtained for proximate composition analyses. A heparinised 173 
capillary tube per sampled fish was filled with blood from the syringe for haematocrit 174 
observations. Haematocrit determination was performed for 6 fish per tank. Haematocrit values 175 
were measured after centrifugation at 6000 revolution per minute (rpm) for 25 min. Blood from 176 
three individuals was used to determine total leucocyte and differential leucocyte numbers. A 177 
10-3 dilution of blood in L-15 was used to determine total leucocyte counts. The cells were 178 
counted in four squares of a haemocytometer per sample and expressed as:  179 
𝑁𝑢𝑚𝑏𝑒𝑟 𝑜𝑓𝑐𝑒𝑙𝑙𝑠 × 𝑚𝑙−1 = 𝑁 × 𝐷𝑖𝑙𝑢𝑡𝑖𝑜𝑛𝐹𝑎𝑐𝑡𝑜𝑟 × 104 180 
where N is the average number of counted blood cells.  181 
For the determination of differential leucocyte counts 3 blood smears were obtained 182 
(for the determination of the percentages of the different leucocyte types in each blood sample 183 
initially and their transformation into numbers of cells × ml-1 of blood according to total 184 
leucocyte numbers). The cells on the blood smears were left to air dry and were stained with 185 
Rapid Romanowsky stain (Raymond A lamb, Eastbourne, UK) in the Institute of Aquaculture, 186 
University of Stirling. The slides were later examined at × 400 magniﬁcation for the 187 
determination of differential leucocyte proportions. Two blood pools from three individuals 188 
per tank (6 individuals in total) were obtained in 1.5 ml eppendorf tubes (400 µl of blood × 189 
sampled fish-1 and thus 1200 µl of blood × tube-1). The blood was left to clot overnight at 4°C 190 
and the next day the pooled plasma was aliquoted into 7 eppendorf tubes (about 40-50 µl) and 191 
stored at -80°C until use for the assessment of salmon immune responses. Head kidney samples 192 
(approximately 5 mm) from three individuals (derived from the same tank), were aseptically 193 
removed according to Secombes (1990), pooled in plastic bjoux vials containing 5ml ice-cold 194 
L-15 medium containing 40 μl heparin (10 IU × ml -1) and used for respiratory burst assays. 195 
Two pools per tank were used to determine the level of superoxide anion (O-2) produced by 196 
head kidney macrophages. 197 
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2.3. Calculations 198 
Feed intake is the calculated amount of food ingested by fish per treatment expressed in g  199 
Feed Conversion Ratio (FCR): 200 
𝐹𝐶𝑅 =
 𝐹𝑒𝑒𝑑 𝐼𝑛𝑡𝑎𝑘𝑒 (𝐹𝐼) (𝑔)
𝑊𝑒𝑡 𝑤𝑒𝑖𝑔ℎ𝑡 𝑔𝑎𝑖𝑛 (𝑔)
 201 
Thermal Growth Rate: 202 
𝑇𝐺𝐶 = (
√𝑊1
3
− √𝑊0
3
(𝑡 × 𝑇)
) × 100 203 
Weight gain (WG): 204 
𝑊𝐺 (
𝑔
𝑑𝑎𝑦
) =
𝑊𝑒𝑡 𝑤𝑒𝑖𝑔ℎ𝑡 𝑔𝑎𝑖𝑛(𝑔)
𝑁𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑑𝑎𝑦𝑠
 205 
Condition Factor (K): 206 
𝐾 =
𝐹𝑖𝑠ℎ 𝑤𝑒𝑖𝑔ℎ𝑡 (𝑔)
𝐹𝑖𝑠ℎ 𝑙𝑒𝑛𝑔𝑡ℎ (𝑐𝑚)3
 207 
 208 
In the above formulae W is the weight of the sampled fish in grams; W0 and W1 are the initial 209 
and the final fish mean weights in grams. 210 
2.4. Isolation of head kidney macrophages (HKM) and estimation of HKM respiratory burst 211 
activity  212 
For the isolation of head kidney macrophages, the head kidney was teased through a 100μm 213 
nylon mesh (BD Falcon; BD Biosciences, Franklin Lakes, NJ, USA) into 2.5 ml Leibovitz 214 
medium (L-15; Sigma-Aldrich) containing 40 µl of heparin (10 IU × ml-1). The mesh was 215 
rinsed with 2.5 ml of the medium and placed on ice. The O-2 production by head kidney 216 
macrophages was measured by the conversion of NBT (Sigma-Aldrich) to formazan, following 217 
the method of Secombes (1990) with some modifications described by Korkea-aho et al. 218 
(2011).  219 
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2.5. Determination of plasma protein concentration and lysozyme activity 220 
Plasma protein content was determined using the Pierce BCA (bicinchoninic acid) Protein 221 
Assay kit (Thermo Scientific, IL, USA) based on the conversion of Cu2+ to Cu1+ under alkaline 222 
conditions (Biuret reaction) using BSA as standard. Plasma lysozyme activity was based on 223 
the lysis of lysozyme sensitive Micrococcus lysodeikticus as described by Korkea-aho et al. 224 
(2011).  225 
2.6. Measurement of plasma natural haemolytic activity 226 
The assay used was based on a method described by (Langston et al., 2001) with modifications. 227 
Briefly sheep red blood cells (SRBC) (Oxoid, UK) were used as target cells at a final 228 
concentration of 2.5 × 108 cells × ml-1 of blood. Plasma was diluted in double serial dilutions 229 
in 0.1 % gelatine-complement fixation buffer (0.1% G-CFB) (1 complement fixation tablet 230 
(Oxoid, UK) and 0.1g of gelatin (Sigma-Aldrich) in 100 ml of warm distilled water) and 25 μl 231 
added to each well of a non-absorbent U-well micro-plate (Sterilin) in duplicate. Ten µl 0.5 % 232 
SRBC suspension was added to each plasma dilution. Controls on each plate comprised 0.1 % 233 
anhydrous Na2CO3 (v/v) (100 % lysis) replacing plasma. G-CFB replacing plasma (0 % lysis) 234 
and plasma blanks (duplicate wells of plasma dilutions with CFT-G buffer replacing SRBC 235 
suspension). The micro-titre plates were incubated at 22°C for 90 min with constant shaking 236 
and the reaction terminated by the addition of 140 μl G-CFB with 20mM EDTA, followed by 237 
centrifugation to spin down the remaining SRBC. After centrifugation 100 μl of the supernatant 238 
from each well was transferred to a new flat-bottomed 96-well non-absorbent micro-titre plate 239 
(Sterilin). The absorbance of the wells was read at 450 nm using a micro-plate reader (Synergy 240 
HT; BioTek Instruments, Winooski, VT, USA) and the percentage lysis of SRBCs calculated. 241 
The absorbance values of samples were corrected by subtracting the absorbance of the sample 242 
blank control (0 % haemolysis). A graph of log x (x = concentration of plasma) (ordinate axis) 243 
vs log y/ (1-y) (y = % SRBC haemolysis) (abscissa axis) was drawn and after estimating the 244 
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volume of plasma giving 50 % haemolysis (H50), and the H50 × ml
-1 of plasma calculated by 245 
dividing the dilution factor of plasma with the estimated plasma volume causing lysis to the 246 
50% of the RBCs in the wells expressed in ml. 247 
2.7. Total plasma Immunoglobulin M (IgM) 248 
The level of plasma IgM in experimental salmon was determined using indirect enzyme linked 249 
immunosorbent assay (ELISA) (Magnadottir and Gudmundsdottir, 1992), with modifications. 250 
Briefly, two replicate rows of a 96-well an Immulon™ 4HBX plate (Thermo Scientific, Maine, 251 
USA) were coated with 100 µl × well-1 serial dilution of purified IgM (Aquatic Diagnostics,  252 
Stirling, Scotland) in 0.05M sodium carbonate/bicarbonate buffer, pH 9.6 (starting from 0.32 253 
mg × ml-1 – 0.00016 mg × ml-1) to form a standard curve of IgM concentration vs. absorbance 254 
at 450 nm. To the remainder of the wells 100 µl of a fold 1/500 and 1/1000 dilution of plasma 255 
from experimental fish was added, diluted in 0.05M sodium carbonate/bicarbonate buffer, pH 256 
9.6, using two replicate wells for each dilution. The plates were then incubated overnight at 257 
4°C and washed 5 times with low salt wash buffer (LSWB; 0.02 M  Trizma base, 0.38 M NaCl, 258 
0.05% (v/v) Tween 20, pH 7.2). The wells were blocked with 250 µl of 3 % w/v dried skimmed 259 
milk (Marvel, Dublin, Ireland) in water and the plates were incubated for 120 min at 21°C. The 260 
casein solution was removed before adding 100 µl of mouse anti-trout/salmon IgM (F11-261 
monoclonal anti trout/salmon IgM - Aquatic Diagnostics, Stirling, Scotland) solution (1:66) in 262 
1 % BSA in LSWB for 1 h at 21°C. Plates were then washed with 5 washes of high salt wash 263 
buffer (HSWB; 0.02 M Trizma base, 0.5 M NaCl, 0.01 % (v/v) Tween 20, pH 7.4) and 264 
incubated for 5 min on last wash before adding 100 µl × well-1 goat anti-mouse 265 
immunoglobulin-G labelled with horseradish peroxidase (HRP) (Sigma/Aldrich) diluted 1: 266 
4000 in conjugate buffer) incubating for 60 min at 21°C. Plates were washed with 5 washes of 267 
HSWB, incubating for 5 min on last wash and the reaction was developed by adding 100 µl × 268 
well-1 of substrate/chromogen (i.e. 15 ml substrate buffer containing 5 µl hydrogen peroxide 269 
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and 150 µl trimethyl-benzidine (TMB) di-hydrochloride) and incubating for 10 min at 22°C. 270 
The reaction was stopped with 50 µl × well-1 of 2M H2SO4 and plate read at 450 nm after 5 271 
seconds in a micro-plate reader (Biotek Synergy HT). 272 
2.8. Plasma anti-protease activity 273 
The method used was designed to detect anti-protease activity in trout plasma, and was based 274 
on the method described by (Ellis, 1990), modified for use in microtitre plates. A hundred 275 
micrograms per millilitre of trypsin solution was prepared by adding 1 ml of 25 mg × ml-1 of 276 
trypsin stock solution (Invitrogen, UK) in 249 ml 0.1 M Tris.HCl (pH 8.2). Plasma samples 277 
were diluted two-fold in the Tris.HCl buffer in round-bottomed 96 well plates (Sterilin), giving 278 
final plasma volumes of 2.5, 1.25, 0.625 and 0.313 µl. In a flat-bottomed 96 well plate, 5 µl of 279 
diluted samples were added to 15 µl trypsin and incubated for 5 min; duplicates were used 280 
where enough plasma was available. Finally, 200 µl of chromogen solution in distilled water 281 
(0.1% Nα-Benzoyl- L -arginine 4-nitroanilide hydrochloride or simply BAPNA (Sigma-282 
Aldrich)) was added to each well. Wells containing only BAPNA solution and Tris.HCl buffer 283 
without the addition of plasma samples served as a zero reference. The plates were then 284 
incubated for 30 min at 22°C before centrifuging them for 6 min at 750 × g. One hundred 285 
microliters from each well was transferred to wells of a flat bottom 96-well plate and the 286 
absorbance measured with a micro-plate reader (Biotek Synergy HT) set on a 5 min kinetic 287 
run, reading every 1 min at 410 nm. Tryptic activity was a measure of the difference in values 288 
at 5 min from the ones at time 0 divided by 5 (units expressed as change of 0.001 units of 289 
absorbance at 410 nm × min-1). The 75 % inhibition value was calculated from the blank 290 
samples, which represent the 100 % inhibition of tryptic activity and reference samples which 291 
represent the 0 % inhibition of trypsin. The volume of plasma required to achieve 75 % 292 
inhibition of trypsin activity was calculated from a graph of % trypsin inhibition against the 293 
volume of plasma used. The units of trypsin inhibited at a percentage of 75 % per ml of plasma 294 
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were obtained by multiplying the estimated value of tryptic activity by 1000; as a unit of trypsin 295 
activity was the amount of trypsin causing decrease in absorbance of 0.001 and dividing this 296 
number by the volume of plasma required to inhibit the activity of trypsin at a percentage equal 297 
to 75 %. The quotient was then multiplied by 1000 to transform μl to ml; so 75 % trypsin 298 
inhibition was expressed in units TI75 × min
-1× ml-1. 299 
2.9. Dietary and NQC fillet composition analysis 300 
The assessment of dietary lipid and FA composition was conducted by The Nutrition Analytical 301 
Services (NAS) of the Institute of Aquaculture, University of Stirling and were run in 302 
duplicates. Dietary crude fat was determined using two different methodologies. Firstly dietary 303 
lipid content was determined following acid hydrolysis using a Soxtec System 1047 304 
hydrolysing unit (Tecator Application note 92/87) followed by exhaustive Soxhlet extraction 305 
using petroleum ether (40–60°C boiling point) on a Soxtec System HT6 (Tecator application 306 
note 67/83) as described by Bell et al. (2001). In addition, dietary lipid fraction was determined 307 
according to the Folch method (Folch et al. 1957) with non-lipid impurities removed by 308 
washing with 0.88% (w/v) KCl. The lipid weight was determined gravimetrically after 309 
evaporation of solvent under nitrogen and desiccation under vacuum for at least 16 h. Dietary 310 
Fatty acid methyl esters (FAME) were prepared from total lipid by acid catalyzed 311 
transesterification as described by Christie (2003) and FAMEs extracted and purified as 312 
described by Tocher & Harvie (1988). FAMEs were separated and quantified by Gas Liquid 313 
Chromatography (GLC) (Carlo Erba Vega 8160, Milan, Italy) using a 30 m × 0.32 mm 314 
capillary column (CP Wax 52CB, Chrompak, London, UK). Hydrogen was used as carrier gas 315 
and temperature programming was from 50 to 150°C at 40°C × min-1 and then to 230°C at 316 
2.0°C × min-1. Individual methyl esters were identified by comparison with known standards 317 
and by reference to published data (Ackman 1980). Peak data was processed using Chromcard 318 
for Windows (version 1.19) computer package (Thermoquest Italia S.P.A., Milan, Italy). Dry 319 
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weight and ash contents of the diets were determined after oven-drying the samples to constant 320 
weight and by ashing dried samples in an oven at 550°C (AOAC 1990). Dietary nitrogen was 321 
determined by Eurofins Scientific (Norway) after total combustion using a Nitrogen-Analyser 322 
(Perkin Elmer, 2410 Ser. II, Norwalk, CT, USA), crude protein content calculated assuming 323 
that proteins contain 16% N. Amino acid composition of the feed raw materials was analysed 324 
by near infrared reflectance (Fontaine et al. 2001) and was also performed by Eurofins 325 
Scientific (Norway). Amino acid composition of compound feed was analysed according to 326 
(Llames & Fontaine 1994) while dietary elemental composition was determined via Inductively 327 
Coupled Plasma - Mass Spectroscopy (ICP-MS) on dietary ash (Shearer 1994). 328 
Pools of homogenised NQC fillet samples (1 pool of 4 individuals per tank) for 329 
chemical  analysis  were  frozen  and  then  thawed  before  blending (whole). Dry matter, 330 
moisture, ash and crude protein levels were determined according to standard methods (AOAC 331 
1990) by oven drying to constant weight. Crude protein from dry NQC samples was estimated 332 
via application of the method described by Kjeldahl, using a Tecator Kjeltec System. Lastly, 333 
crude fat from dried NQC carcass was determined using petroleum ether (40–60°C boiling 334 
point) on a Soxtec System HT6 (Tecator application note 67/83) (Christie 2003). 335 
2.10. Statistics 336 
The statistical analysis was carried out with the help of the R language (R Core Development 337 
Team, 2014) and its lme4 package (Bates et al., 2014). Similar statistical analyses are presented 338 
by Espe et al. (2012) and Hartviksen et al. (2014).  To investigate the effect of the diets on the 339 
haematological and immunological responses, the data were fitted in two different models 340 
without (only the tank effect was added) and with the feed variable (tank effect nested within 341 
the dietary effect), which were then nested and compared with a likelihood ratio test (LRT).  342 
Feed intake (FI) and feed conversion ratio (FCR) over the full trial period and during 343 
first and second study period were modelled as ordinary linear models since there was no 344 
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multilevel structure (only one observation per tank). Gutted weights are available from a 345 
subsample of fish at the end of the trial. Daily WG for the same period was modelled with the 346 
help of splines to allow the identification of non-linear responses of the diets in time. Since 347 
there were three weight points available, the degree of freedom for the spline was constrained 348 
to 2. Two models were then fitted without and with the dietary effect, and compared with LRT. 349 
The modelling of the condition factor was conducted by fitting a length-weight 350 
relationship and adding the treatment as a covariate to the model. Since whole fish (ungutted) 351 
weights were available at the end of the trial, these were used as a predictor, in order for the 352 
model to adjust for an average-sized sampled fish and for a direct comparison to be possible. 353 
Lastly, two nested models were fitted, without and with the dietary effect, and compared with 354 
a LRT as above.  355 
Composition percentages were modelled with an ordinary linear model (only one 356 
observation per tank) using an arcsin transformation to the responses which were expressed as 357 
a percentage of wet weight and adding the mean weight of the sample as a covariate. Sample 358 
mean weights were mean-centred before the analysis so that the results are easy to interpret as 359 
for the average-sized sampled fish. 360 
Models demonstrating possibilities (P values) of 0.1 were selected for the description 361 
of data. For the modelled immune responses affected by the dietary treatments, the results are 362 
summarised as graphs with the mean response and 95% confidence interval. Confidence 363 
intervals were solved by a posterior simulation from the statistical model with 1500 random 364 
draws (Gelman and Hill, 2007). Differences among dietary treatments were revealed when the 365 
95% confidence intervals for a certain response of a dietary group did not overlap with the 366 
mean values of the same response from another group. 367 
3. Results and Discussion 368 
3.1. Diets  369 
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Total replacement of FM or FO and/or both marine ingredients in the experimental feeds was 370 
done in order to meet or exceed salmon known nutrient requirements (NRC 1993). In the 371 
present study the selection of the protein and oil sources was based on previous studies 372 
performed by EWOS, reporting high protein and energy digestibility (Crampton personal 373 
communication) as well as adequate growth (Crampton et al. 2010; Hartviksen et al. 2014; 374 
Hatlen et al. 2014). Nonetheless, the dietary amino acid profiles of the six experimental diets 375 
differed as a consequence of FM substitution with alternative protein sources (Table 2) 376 
reflecting the amino acid composition of the different ingredients used. Lower levels for most 377 
indispensable amino acids (IAA) were observed in the treatments that were free from marine 378 
proteins (VP, VP/VO and MFABP diet) in comparison to the marine protein based diets, with 379 
the exception of leucine and phenylalanine which were found at higher levels in FM-free feeds. 380 
The changes among IAA were less pronounced to those reported by Torstensen et al. (2008) 381 
regarding the differences between diets with partial substitution of FM and FO with plant 382 
derived ingredients compared to a fully marine based control feed. Mambrini and Kaushik 383 
(1994) and Green et al. (2002) reported that IAA: DAA ratio could affect several performance 384 
parameters in fish. Herein, dietary IAA: DAA ratios were kept constant among treatments. The 385 
dietary FA concentrations of the experimental diets are presented in Table 3. Lower amounts 386 
of saturated and monounsaturated FAs and higher levels of total n-6 and n-3 polyunsaturated 387 
FAs were observed for the VO-based diets. For the last group of FAs both marine based diets 388 
presented higher 20:5n-3 (eicosapentaenoic acid-EPA) levels while 22:6n-3 (docosahexaenoic 389 
acid-DHA) was higher for the VO-based feeds due to the inclusion of algal oils, characterised 390 
by increased levels in the aforementioned FAs which is in accordance to previous algal oil 391 
feeding studies performed by Carter et al. (2003) and Miller et al. (2007). Furthermore, n-3 to 392 
n-6 PUFAs ratio demonstrated a gradual decrease in the diets in the following order: 393 
MB=MBABP>VP>VO>VP/VO=MBABP. 394 
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3.2. Growth and chemical composition of NQC fillet samples 395 
The results of this study demonstrated negligible mortality (<1%) in all dietary groups during 396 
the full experimental period, which is a primary indication that all of the diets fulfilled the 397 
nutrient requirements of salmon (Table 4).  398 
However, salmon performance in terms of expected WG and FI for the first and full 399 
period of the study were largely influenced by the initial size differences of the fish assigned 400 
to the different diets. Reassignment of salmon populations in the tanks prior to the initiation of 401 
the feeding trial, could have given even more sound and clear results regarding the overall 402 
performance of salmon. However, comparable to the present study, were also the differences 403 
in salmon starting weights before the commencement of a similar commercial feeding study 404 
conducted by EWOS and reported by Crampton et al. (2011), utilising a commercial EWOS 405 
marine based and a low FM diet in Atlantic salmon post-smolts reared in sea cages. All the 406 
above, highlight the difficulties when conducting large scale scientific studies involving 407 
salmon of large size like the present one. However, this should not detract from the significance 408 
of this investigation as important conclusions could still be drawn from it.  409 
Salmon fed the control MB diet presented higher FI than the rest of the groups (Fig. 410 
1B) (since the expected mean FI values of the MB group did not overlap with the 95% C.I. of 411 
the other dietary groups). Furthermore, VP-fed salmon exhibited higher expected FI than the 412 
MBABP, MFABP and VP/VO groups, while the latter group, also demonstrated lower FI than 413 
VO-fed salmon. Studies have reported that total or partial replacement of FM  in salmonid diets 414 
can negatively affect the FI in fish (Gomes et al. 1995; De Francesco et al. 2004; Kaushik et 415 
al. 2004; Espe et al. 2006) and this could be due to the lack in certain FM components acting 416 
as feeding stimulators (Kousoulaki et al. 2012). Moreover, self-selecting feeding trials have 417 
shown that rainbow trout prefer diets containing FO over those with VO, suggesting that some 418 
fish do actively select feeds based on the oil origin (Geurden et al. 2005, 2007). Herein, the VP 419 
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diet was supplemented with higher levels of FO in order to compensate the lack of residual 420 
fish-derived lipid found in the FM fraction of the marine based diets resulting in a FA profile 421 
which was more closely related to that of the marine based diets. Liland et al. (2012), proposed 422 
that dietary FA composition might be a regulating component of Atlantic salmon appetite. This 423 
could explain the numerically lower FI in VO-fed fish in comparison to the VP group and the 424 
absence of differences between MBABP salmon in contrast to the former group, despite the 425 
size difference at the start of the study. Hence the suggestion made by Liland et al. (2012) 426 
seems to be valid for Atlantic salmon post-smolts. In contrast to the present findings, Carter et 427 
al. (2003) and Miller et al. (2007) reported unaffected FI in juvenile Atlantic salmon fed diets 428 
containing just algal oils, a combination of algal and VO compared to salmon fed fully or 429 
partially FO based diets. Unaffected growth was also reported for the aforementioned dietary 430 
groups compared to the FO-fed fish, which is in agreement with our results. 431 
  For the same period the MB control group exhibited higher expected weight gain (WG) 432 
than the majority of the dietary groups except for the VO-fed group (Fig. 1A). The majority of 433 
the other groups exhibited no differences in WG. The only exception was the VP/VO salmon 434 
which exhibited lower WG in contrast to the VO-fed fish. The initial size discrepancies 435 
promoting contrasting FIs and thus further size differences among the latter groups of salmon 436 
seem to be the main reason for the last observation. Higher FCR values were obtained for the 437 
MB and VP salmon, during the first period of the feeding trial (Fig. 1C), revealing the lower 438 
efficiency of salmon in the utilisation of  dietary nutrients from the two aforementioned feeds, 439 
compared to the other dietary treatments. 440 
Both expected FIs and WGs demonstrated no differences among the six dietary groups 441 
during the second period. Nevertheless, a significant increment in FI was observed for the 442 
MBABP, MFABP and VP/VO groups (the expected mean FI values for these groups during 443 
the second period did not overlap with the 95% C.I. of the FI values obtained during the first 444 
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period), while a rather substantial but not significant increase was also witnessed for the VO 445 
group for this period compared to the initial phase. Furthermore, a significant reduction in 446 
expected WG was observed for the MB group at the second period in comparison to the initial 447 
one while no significant differences were witnessed for all other groups. Increased feed 448 
consumption and thus growth (defined as “compensatory growth”) after periods of restricted 449 
FI have been demonstrated in Atlantic salmon (Johansen et al. 2001; Torstensen et al. 2008). 450 
The above findings demonstrate that Atlantic salmon requires long adaptation periods before 451 
accepting any diet with high levels of alternative protein and lipid sources as previously 452 
reported by Torstensen et al. (2008).  453 
Overall, MB salmon had a higher overall FI by the end of the trial compared to most of 454 
the other dietary groups, except VP salmon (Fig. 1B). In addition, higher overall FI was 455 
observed for VP-fed salmon in comparison to the MBABP salmon and the marine-free 456 
(MFABP and VP/VO) groups of salmon. The above observations highlight the importance of 457 
the oil fraction on the acceptability of aquafeeds by salmonids (Geurden et al. 2005; 2007; 458 
Liland et al. 2012), as lower FI was obtained for the VO group regardless of the greater initial 459 
size of these fish compared to VP salmon. Furthermore, higher WG was observed for the MB 460 
salmon compared to the MBABP, MFABP and VP/VO fed salmon (Fig. 1A). FCR values for 461 
the full duration of the trial were found to be higher for the MB and VP salmon in contrast to 462 
all other dietary groups while no differences were observed between the former groups (Fig. 463 
1C). Therefore, among the two marine based groups, MB salmon exhibited lower feed 464 
efficiency while MBABP salmon with intermediate growth performance values demonstrated 465 
better efficiency in the utilisation of dietary nutrients. Excluding VP salmon, the low FCR 466 
values demonstrated for the majority of the experimental groups during the full study period, 467 
indicate that judicious selection of alternatives to FM and FO and careful formulation of salmon 468 
feeds in order to satisfy their nutrient requirements could promote adequate growth even when 469 
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both marine-derived proteins and lipids are fully excluded. Espe et al. (2006) reported equal 470 
FCR values in Atlantic salmon fed a FM-based compared to FM-free diets, which in the case 471 
of the present study was true only for the MBABP compared to the VP and the two marine-472 
free dietary groups. However, in the latter study marine based by-products were included in 473 
the experimental diets in order to improve their acceptance by the fish. Contrary to our findings, 474 
were also the higher FCR values reported in Atlantic salmon post-smolts fed on diets where 475 
marine and plant derived ingredients from commercial salmon diets were partially substituted 476 
by terrestrial ABPs (Hatlen et al. 2013, 2014). Similar to our results, unaffected FCRs were 477 
also reported in Atlantic salmon fed low marine ingredient diets compared to a fully marine 478 
dietary group (Torstensen et al. 2008). Moreover, most FO replacement studies for Atlantic 479 
salmon diets demonstrated unaffected FCRs for VO- in comparison to FO-fed salmon which 480 
are partially in agreement with the present findings (Bell et al. 2002; Torstensen et al. 2005; 481 
Karalazos et al. 2007). 482 
Condition factor (K) values at the end of the trial ranged between 1.25 and 1.75 for the 483 
majority of the fish, describing salmon with fairly good to excellent quality (Barnham and 484 
Baxter 1998). Expected K values were found to be higher for the VP group, while salmon fed 485 
the VO diet exhibited lower K values compared to the rest of the groups. Moreover MBABP, 486 
salmon presented higher K values than the MB group and salmon maintained on the marine 487 
free diets (MFABP and VP/VO). Furthermore, higher K was obtained for VP/VO salmon in 488 
comparison to the MB salmon, while no difference was noticed between the latter group and 489 
MFABP salmon (Fig. 1D). Since K factor describes the relationship between the full (ungutted 490 
whole fish) weight and salmon length, the high values obtained for VP-fed salmon is an 491 
indication of thicker bodies whereas the low K values observed for the VO-fed fish point at 492 
much leaner fish compared to the other groups. In general, Atlantic salmon post-smolts of 2.5 493 
kg (mean final salmon weight for all groups) are characterised by increased muscle growth, 494 
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hepatic and visceral fat deposition (Shearer 1994). Therefore, the increased K values exhibited 495 
for the salmon maintained on the VP diet could actually be an indirect indication of higher 496 
hepatic and visceral fat accumulation, as no differences in fillet fat levels were observed among 497 
the dietary groups. Despite the fact that the opposite trend was illustrated for the VO-fed group, 498 
the assumption of lower adiposity in these fish requires a more thorough investigation. Studies 499 
by Ruyter et al. (2006) and  Jordal et al. (2007) demonstrated that high dietary VO or fully VO-500 
based diets could induce visceral and/or hepatic adiposity, while Torstensen et al.  (2011) 501 
reported increased visceral adiposity in salmon fed diets with high levels of VPs and VOs 502 
respectively. Since fat levels in the liver, intestine and pancreas were not estimated in the 503 
current study no further comments could be made on this matter. In contrast to our findings, 504 
Espe et al. (2006) demonstrated unaltered K values in Atlantic salmon fed VP-based diets. 505 
Furthermore, Torstensen et al. (2008) reported lower K values in Atlantic salmon maintained 506 
on diets with high levels of VPs and moderate or high supplementation with VOs compared to 507 
fish fed a marine-based diet or a diet containing a moderate inclusion of VPs and high inclusion 508 
of VOs. 509 
Proximate analysis of the NQC samples revealed no differences in moisture, crude 510 
protein, lipid and ash levels among the six dietary groups, suggesting similar levels of nutrient 511 
accumulation in the salmon fillets. Similarly, previous studies have reported unaffected fillet 512 
composition in salmonids fed fully VO-based feeds (Karalazos et al., 2007; Turchini and 513 
Francis, 2009). Contrary to our findings, a body of literature has demonstrated reductions in 514 
the lipid content and subsequent increases in the protein levels, in the fillets of VO-fed 515 
salmonids (Bell et al., 2002, 2001; Jokumsen and Alsted, 1990). The latter findings combined 516 
with the presence of increased hepatic fat levels, have triggered the hypothesis that VOs could 517 
induce adiposity (Bell et al., 2002). Recently, Torstensen et al. (2011) demonstrated that diets 518 
with high levels of both VPs and VOs could promote visceral adiposity and metabolic 519 
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imbalance which could affect salmon health. Based on the present data, the only indication for 520 
increased visceral adiposity as was previously mentioned were the high K values demonstrated 521 
for the VP group while no similar assumptions could be made for the other groups. 522 
3.3. Haematology and innate immune responses 523 
The haematological and immunological responses of salmon at the end of the trial are 524 
summarized in Table 5. No significant differences were revealed for the majority of the 525 
estimated haematological parameters. However, lower expected haematocrits were obtained 526 
for the MB group compared to the MBABP, MFABP and VP/VO groups, while the latter two 527 
groups of salmon presented higher values in comparison to the VO-fed group (Fig. 2A). 528 
Therefore, it is apparent that the elimination of the FM fraction from the diets resulted in 529 
increased haematocrit, while the elimination of both fractions promoted even higher 530 
haematocrit which could imply improved health status for the aforementioned groups. Most of 531 
the existent reports of FM and FO substitution with alternative feed ingredients are 532 
contradictory to the present findings. Twibell et al. (2012) reported lower haematocrit levels in 533 
coho salmon and rainbow trout (Oncorhynchus mykiss) fed on VP and ABP in combination 534 
with VO diets compared to salmon fed MB diets. Furthermore, complete replacement of dietary 535 
FM with ABPs did not significantly affect haematocrit levels in previous feeding trials with 536 
coho salmon (Higgs et al. 1979) or  rainbow  trout (Steffens 1994) compared with fish fed a 537 
FM control diet. On the other hand Hemre et al. (1995; 2005) reported decreased haematocrit 538 
levels in Atlantic salmon fed on diets with increased substitution of FM with soybean products 539 
or increased dietary inclusion of crude fibre which is the case at high levels of FM replacement 540 
with most plant derived feed proteins. In addition, Thompson et al. (1996) reported unaffected 541 
haematocrit in Atlantic salmon fed on diets with complete substitution of FO with sunflower 542 
oil (SO). Nonetheless, haematocrit values for all dietary salmon groups were found to be within 543 
normal ranges varying from 43-60%, indicating healthy fish (Hardie et al. 1990; Waagbø et al. 544 
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1994; Thompson et al. 1996) without compromised blood oxygen carrying capacity, since there 545 
was lack of anaemia which could be related to iron or other mineral deficiencies.  546 
No differences in total and differential leucocyte numbers were detected among the six 547 
dietary groups of Atlantic salmon post-smolts, indicating the modulation of similar levels and 548 
patterns in leucocyte production in the 6 groups of fish. Thompson et al. (1996) reported that 549 
Atlantic salmon parr fed on diets with complete replacement of FO with sunflower oil (SO) did 550 
not exhibit differences in total and differential circulating leucocyte levels. On the contrary 551 
Rumsey et al. (1994), showed that rainbow trout fed on soy proteins presented increased 552 
numbers of circulating leucocytes. 553 
No differences regarding credible plasma haemolytic activity, plasma protein and total 554 
IgM and expected respiratory burst activity in stimulated and non-stimulated head kidney 555 
macrophages, were observed among the six dietary salmon groups. Contrary to this, reduced 556 
levels of total plasma IgM were reported by Jalili et al. (2013) in rainbow trout fed on diets 557 
with total substitution of FM with VPs. Furthermore, Jalili et al. (2013) and Sitjà-Bobadilla et 558 
al. (2005) reported decreased alternative complement activity in rainbow trout and gilthead sea 559 
bream fed diets with 100% substitution of FM with VPs. In agreement with the present 560 
findings, no differences in HKM respiratory burst activity were observed in feeding trials 561 
where Atlantic salmon and rainbow trout were fed on FM-based diets supplemented only with 562 
soybean oil or linseed oil (Kiron et al. 2004; Seierstad et al. 2009). Furthermore, Carter et al. 563 
(2003) demonstrated no changes in total immunoglobulin and protein levels, anti-protease 564 
activity and circulating leucocytes respiratory burst activity for Atlantic salmon fed diets with 565 
complete replacement of FO with canola oil (CO) or 2 blends of CO and FO or CO and algal 566 
oil which are in line with the present findings. Similar results were also obtained by (Thompson 567 
et al. 1996) who demonstrated no differences in plasma complement, anti-protease and HKM 568 
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respiratory burst activities of Atlantic salmon fed full soybean oil diets compared to FO fed 569 
salmon.  570 
Higher expected lysozyme activity was demonstrated for MB salmon compared to all 571 
other dietary groups (Fig. 2B). No differences regarding lysozyme activity were witnessed 572 
amongst the MBABP group compared to the rest of the experimental groups. Reductions in 573 
lysozyme activity could render fish susceptible to diseases (Saurabh & Sahoo  2008). Several 574 
disease resistance selection studies, however, have observed a negative correlation between 575 
survival rate and lysozyme activity in Atlantic salmon challenged against several bacterial 576 
diseases (Røed et al. 1993; Fevolden et al. 1994; Lund et al. 1995), demonstrating that the 577 
resistance of salmon against diseases might be more dependent on other immune responses or 578 
their efficiency in detoxifying from the by-products of immune activation. Moreover, Fevolden 579 
et al. (1994) suggested that lysozyme activity following a disease challenge in salmonids, is 580 
not a reflection of a superior immune mobilisation, but an indication of stress induction which 581 
could increase the susceptibility of challenged salmonids. Therefore, increased stress as a result 582 
of the overall higher stocking density (promoted by their increased growth) in the tanks hosting 583 
MB salmon, at the first period of the study, could have promoted stress and higher lysozyme 584 
activity in these fish. This could also be supported by their inhibited growth performance 585 
compared to the other groups during the second study period (Pickering 1993; Plisetskaya & 586 
Duan 1994). 587 
Furthermore, higher expected anti-protease activity was exhibited for MFABP salmon 588 
compared to MB, MBABP and VO salmon while higher anti-protease activity was observed 589 
for the VP and VP/VO dietary groups in contrast to the MBABP group (Fig. 2C). Increased 590 
plasma anti-protease activity in salmon fed diets containing only plant proteins (VP and 591 
VP/VO) or high levels of plant proteins (MFABP) could be a favourable feature against several 592 
bacterial infections (Ellis 1990). Several plant extracts used as feed additives in previous 593 
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studies, demonstrated an increase in plasma anti-protease activity (Rao & Chakrabarti 2004; 594 
Kaleeswaran et al. 2011).  It is possible that high levels of plant derived ingredients and more 595 
specifically plant protein concentrates even after processing manipulations targeting the 596 
improvement of their nutritional quality might contain certain levels of bioactive compounds 597 
exerting an immunostimulatory activity to the fish.  598 
The findings of the current study suggest that marine protein-, marine oil- and marine-599 
free diets can be utilised satisfactorily by Atlantic salmon post-smolts, compared to commercial 600 
feed formulations, stimulating both adequate growth and innate immune responses. However, 601 
longer adaptation periods might be required for salmon to fully accept these diets. Moreover, 602 
dietary FO substitution seems to be easier than FM replacement. The future application of such 603 
feeds will depend on the availability and prices of these prime protein and lipid alternatives, 604 
which currently do not consist a cost-efficient solution for the production of aqua-feeds 605 
compared to the feedstuffs currently used in commercial feed formulations. Future studies on 606 
similar levels of FM and FO replacement in salmon feeds should focus on the testing of such 607 
treatments under the stressful cage-culture conditions and the assessment of salmon resistance 608 
and performance against industrially important diseases. 609 
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Figure Captions 1 
Figure 1. Expected performance indices at different study points. (A) Feed Intake (FI); (B) 2 
Daily weight gain (WG); (C) Feed Conversion Ratio (FCR) of the Atlantic salmon groups over 3 
the periods 1 and 2 and the full duration of the trial and (D) condition factor (K) of the salmon 4 
groups for the full period of the trial. These parameters were affected by the diets and the results 5 
are summarised as graphs with the expected mean response and 95% confidence intervals. 6 
Confidence intervals were solved by a posterior simulation from the statistical model with 1500 7 
random draws. Significant differences among dietary groups are revealed when the confidence 8 
intervals bars for a certain response of a dietary group do not overlap with the mean values of 9 
the same response from another group. The effect of feeds on the above growth performance 10 
indices was confirmed by fitting a model without the dietary effect (only tank effect) and with 11 
it (tank effect nested within it) and comparing the models with a likelihood ratio tests (LRT). 12 
FI and FCR are modelled as ordinary linear models since there is no multilevel structure (only 13 
one observation per tank) whereas WG modelled with the help of splines to allow non-linear 14 
response in time. FI and WG are expressed as g × fish-1× day-1 to adjust for the different 15 
duration of the periods. Diet abbreviations: MB, European commercial marine based diet 16 
(2011-12); VP, vegetable protein diet; VO, vegetable oil diet; VP/VO, vegetable 17 
protein/vegetable oil diet; MBABP, Non-EU commercial marine based diet with inclusion of 18 
animal-by-product (2011-12); MFABP, fish free animal-by-product diet. Significant 19 
differences (P values < 0.05) between dietary groups are denoted by different letters. 20 
Figure 2. Expected levels of the affected haematological and immunological responses.(A) 21 
Haematocrit (%); (B) Lysozyme (Units × min-1 × ml-1); Plasma anti-protease activity (Units 22 
TI75 × ml
-1); (%); of the dietary groups of Atlantic salmon post-smolts for the full period of the 23 
trial. These parameters were affected by the diets and the results are summarised as graphs with 24 
the expected mean response and 95% confidence intervals. Confidence intervals were solved 25 
by a posterior simulation from the statistical model with 1500 random draws. Significant 26 
differences among dietary groups are revealed when the confidence intervals bars for a certain 27 
response of a dietary group do not overlap with the mean values of the same response from 28 
another group. The dietary effect on the health responses was confirmed by fitting a model 29 
without the dietary effect (only tank effect) and with it (tank effect nested within it) and 30 
comparing the models with a likelihood ratio tests (LRT).The modelling for all above 31 
parameters Diet abbreviations: MB, European commercial marine based diet (2011-12); VP, 32 
vegetable protein diet; VO, vegetable oil diet; VP/VO, vegetable protein/vegetable oil diet; 33 
MBABP, Non-EU commercial marine based diet with inclusion of animal-by-product (2011-34 
12); MFABP, fish free animal-by-product diet. Significant differences (P values < 0.05) 35 
between dietary groups are denoted by different letters. 36 
 37 
 38 
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Table 1 Feed formulations of the six diets. 1 
FEED FORMULATION 
Ingredient composition (g × kg-1) 
DIETS 
MB MBABP MFABP VP VO VP/VO 
LT Fishmeala 300.0 200.0 - - 300.0 - 
Plant Protein Concentratesb 255.3 207.6 386.8 528.1 255.3 528.1 
Starch Binder 87.9 85.4 88.6 92.8 87.9 92.8 
Animal By-Productsc - 155.0 160.0 - - - 
Amino Acidsd 9.1 7.4 15.2 1.7 9.1 1.7 
Vitamin/Mineral & Pigment Mixese 35.9 35.9 41.9 41.9 35.9 41.9 
Fish Oilf 148.0 157.6 - 177.0 - - 
Plant Lipidsg 163.8 150.9 220.3 138.4 239.0 228.2 
Algal Lipidsh - - 87.2 - 72.8 87.2 
       
Diet abbreviations: MB, European commercial marine based diet (2011-12); MBABP, Non-EU 2 
commercial marine based diet with inclusion of animal-by-products (2011-12); MFABP, fish free 3 
animal-by-product diet; VP, vegetable protein diet; VO, vegetable oil diet; VP/VO, vegetable 4 
protein/vegetable oil diet. a LT Fishmeal (low temperature fishmeal from Egersund Sildeoljefabrikk AS, 5 
Egersund, Norway): superior quality FM due to the fact that is treated at lower drying temperatures 6 
allowing FM to keep optimal essential amino acid profile, low biogenic amines with an apparent protein 7 
digestibility coefficient of 90.2%; b Vegetable proteins: includes protein concentrates from soy (Imcopa, 8 
- Importação, Exportação e Indústria de Óleos Ltda., Araucária - Paraná, Brazil) and pea (AgriMarin, 9 
Stavanger, Norway) and wheat gluten (Henan Tianguan, Nanyang City, China); c Animal by-products: 10 
includes Poultry by-product meal (Poultry by-product meal, GePro Geflügel-Protein Vertriebs- GmbH 11 
& Co, Diepholz, Germany) and porcine blood meal (Daka Proteins, Løsning, Denmark); d Amino acids 12 
from Evonik Degussa International AG, Hanau, Germany; e proprietary of EWOS Innovation; Plant 13 
lipids: includes mainly rapeseed oil (Cargill PLC, Lincoln, UK); f Fish Oil: Capelin oil (Egersund 14 
Sildeoljefabrikk AS, Egersund), Norway; Plant Lipids: includes rapeseed oil; h Algal lipids: includes oil 15 
from heterotrophically grown algal species (Origin Unknown).16 
Table 3 Chemical composition of the experimental diets (g × kg-1 of dietary wet weight) 
Chemical 
composition (w.w.) 
DIETS  
MB MBABP MFABP VP VO VP/VO 
Moisture (g × kg-1) 72.65 60.85 81.15 69.20 76.75 85.95 
Protein N*6.25 (g × kg-1) 390.00 373.00 385.00 373.00 385.50 380.00 
Lipid (g × kg-1) 374.15 355.60 358.45 352.15 373.45 342.35 
Crude fibre (g × kg-1) 9.05 9.85 10.85 10.80 8.05 10.80 
Ash (g × kg-1) 41.80 39.35 36.10 20.45 42.60 16.25 
P (g × kg-1) 11.10 11.90 11.50 8.20 11.85 9.30 
Ca (g × kg-1) 13.55 14.25 12.50 8.45 15.10 9.90 
Mg (g × kg-1) 1.50 1.15 1.15 0.85 1.30 0.80 
Zn (mg × kg-1) 272.50 281.00 281.00 254.50 258.50 275.50 
AMINO ACID COMPOSITION       
Alanine (g × kg-1) 20.00 22.50 22.45 19.45 19.95 19.55 
Arginine (g × kg-1)* 23.95 22.85 23.00 22.10 24.05 22.35 
Cysteine (g × kg-1) 4.55 4.55 4.40 4.95 4.50 5.00 
Glutamate (g × kg-1) 68.00 59.90 66.30 78.70 68.40 79.20 
Glycine (g × kg-1) 19.45 21.65 21.20 13.50 24.25 13.40 
Histidine (g × kg-1)* 8.85 9.25 7.75  8.55 8.90 8.35 
Hydroxyproline(g × kg-1) 1.35 2.70 4.50 0.10 1.05 0.10 
17.20 
43.95 
Isoleucine (g × kg-1)* 18.05 16.70 15.65   17.60 17.75 
Leucine (g × kg-1)* 29.50 31.65 41.60   43.00 29.30 
Lysine (g × kg-1)* 30.55 28.95 27.50 30.00 30.65 29.50 
8.55 
0.10 
Methionine (g × kg-1)* 9.20 8.30 8.00  8.40 9.35 
Ornithine (g × kg-1) 0.15 0.15 0.20 0.10 0.15 
Phenylalanine (g × kg-1)* 16.85 16.90 18.40 20.10 16.90 20.30 
25.60 
18.95 
14.80 
Proline (g × kg-1) 20.60 20.55 23.90 23.70 20.35 
Serine (g × kg-1) 17.70 17.50 17.90 17.75 17.75 
Threonine (g × kg-1)* 15.95 15.45 14.00  14.50 15.80 
Tryptophane (g × kg-1)* 4.40 4.20 3.70  3.90 4.05 3.45 
Tyrosine (g × kg-1) 13.10 13.15 13.65  15.50 13.35 15.35 
17.95 Valine (g × kg-1)* 19.75 19.00 17.00  18.60 19.55 
Sum IAA 177.00 178.66 176.95 185.88 176.15 196.15 
Sum DAA 164.90 162.35 170.40 174.35 177.35 183.10 
IAA/DAA 1.07 1.07 1.01 1.07 1.04 1.05 
       
Diet abbreviations: MB, European commercial marine based diet (2011-12); MBABP, Non-EU 
commercial marine based diet with inclusion of animal-by-products (2011-12); MFABP, fish free 
animal-by-product diet; VP, vegetable protein diet; VO, vegetable oil diet; VP/VO, vegetable 
protein/vegetable oil diet.  
* Amino acids followed by an asterisk are Indispensable (Essential) Amino Acids (IAA) for salmon 
and the ones without are dispensable (non-essential) amino acids (DAA). 
The data presented are consolidated averages of the two dietary batches used for the study.
Table 3 Fatty acid composition of the experimental diets (g × kg-1 of dietary wet weight) 
Fatty acid  
composition (g × kg-1)(w.w.) 
DIETS 
MB MBABP MFABP VP VO VP/VO 
14:0 31.50 31.50 17.00 32.00 18.00 15.50 
15:0 2.50 2.50 1.00 3.00 1.50 1.00 
88.50 16:0  110.50 117.00 100.00 118.00 89.50 
18:0  25.50 28.50 26.50 30.00 24.00 24.00 
20:0 3.50 4.00 4.50 4.00 4.50 4.50 
3.00 22:0 1.50 2.00 3.00 2.00 3.00 
Sum saturated 143.25 154.00 135.00 157.00 122.50 121.00 
16:1n-7 37.00 37.00 5.50 36.00 8.00 2.50 
16:1n-9 2.50 2.00 1.50 2.50 1.50 1.00 
18:1n-7  29.00 28.50 22.50 28.00 24.00 21.50 
18:1n-9 342.00 340.00 434.50 329.00 438.50 436.50 
20:1n-7 2.00 2.00 <1.00 2.50 1.00 <1.00 
20:1n-9  72.50 68.50 11.00 70.00 20.00 10.00 
20:1n-11 3.00 2.50 <1.00 2.50 <1.00 <1.00 
22:1n-9 8.50 8.00 3.00 8.50 4.00 3.00 
22:1n-11 68.00 64.00 3.00 62.50 14.00 1.00 
2.00 24:1n-9 6.00 6.50 2.00 6.00 3.50 
Sum MUFAs 570.25 558.75 484.00 547.25 515.25 478.50 
18:2n-6 108.50 110.00 165.00 126.00 146.00 172.50 
18:3n-6 <1.00 1.00 <1.00 <1.00 <1.00 <1.00 
20:2n-6 2.00 2.00 1.00 2.00 1.00 1.00 
20:3n-6 <1.00 <1.00 1.00 <1.00 1.00 1.00 
20:4n-6 2.50 2.50 2.50 2.50 2.00 2.00 
Sum n-6 PUFAs 115.00 116.50 170.50 132.50 151.00 177.50 
18:3n-3 45.00 42.50 57.50 41.50 59.50 61.50 
18:4n-3 12.00 11.00 1.00 11.00 2.50 1.00 
20:3n-3 <1.00 <1.00 <1.00 <1.00 <1.00 2.00 
20:4n-3 2.50 2.50 2.00 2.50 2.00 2.00 
20:5n-3 33.00 32.50 3.00 32.00 9.00 2.50 
22:5n-3 3.00 3.00 1.00 3.50 1.50 1.00 
99.00 
169.00 
0.95 
22:6n-3 41.50 42.50 93.00 37.00 89.00 
Sum n-3 PUFAs 138.00 135.00 158.50 128.50 164.50 
n-3/n-6 1.20 1.16 0.93 0.97 1.09 
       
Diet abbreviations: MB, European commercial marine based diet (2011-12); MBABP, Non-EU 
commercial marine based diet with inclusion of animal-by-products (2011-12); MFABP, fish free 
animal-by-product diet; VP, vegetable protein diet; VO, vegetable oil diet; VP/VO, vegetable 
protein/vegetable oil diet.  
The data presented are consolidated averages of the two dietary batches used for the study.
Table 4 Performance factors and NQC proximate composition of Atlantic salmon parr fed the experimental diets. 
Performance parameters DIETS 
MB MBABP MFABP VP VO VP/VO 
Initial weight (g)   992.3±119.8   901.8±58.1 924.8±32.3 940.7±127.2 983.9±66.8 892.9±29.9 
Intermediate weight (g) 2041.3±224.6 1858.4±111.9 1856.7±113.1 1927.1±301.2 2014.7±142.4 1795.7±39.3 
Final weight (g) 2608.7±268.6 2417.5±171.1 2415.6±197.1 2528.9±417.0 2626.9±286.8 2381.7±11.2 
**Feed Intake 1st Period (g×fish-1×day-1) 8.65±0.75A 6.16±0.62B 5.87±0.98B 7.50±1.79C 6.89±0.72BC 5.78±0.46B 
Feed Intake 2nd Period (g×fish-1×day-1) 8.11±1.33 7.69±1.21 7.53±1.23 8.29±1.56 8.30±1.58 8.12±0.70 
Feed Intake full Period (g×fish-1×day-1) 8.38±1.04A 6.93±0.91B 6.70±1.11B 7.90±1.67AC 7.60±1.15BC 6.95±0.58B 
*Wt gain (g× fish -1×day-1) 1st Period 10.84±0.52A 8.63±0.52BC 8.22±0.77BC 8,98±1.475BC 9.59±0.76B 8.10±0.32C 
Wt gain (g×fish -1×day-1) 2nd Period 8.11±2.01 7.87±1.77 7.87±1.80 8.48±1.68 8.58±2.09 8.25±0.55 
Wt gain (g×fish -1×day-1) full Period 9.74±0.71A 8.32±0.78B 8.08±0.87B 8.78±1.48AB 9.18±1.25AB 8.16±0.06B 
†FCR 1st Period 0.80±0.05A 0.71±0.03B 0.71±0.05B 0.83±0.07A 0.72±0.03B 0.71±0.06B 
FCR 2nd Period 1.02±0.11A 0.99±0.09B 0.97±0.08B 0.98±0.03B 0.98±0.08AB 0.98±0.02B 
FCR full Period 0.91±0.05A 0.85±0.05B 0.84±0.05B 0.90±0.04A 0.85±0.03B 0.85±0.04B 
‡Condition Factor (K) end of trial 1.52±0.11A 1.54±0.12B 1.51±0.11AC 1.61±0.12D 1.46±0.10E 1.52±0.10C 
Mortalities (%) 1st period 0.3±0.5 0 0 0 0.3±0.5 0 
Mortalities (%) 2nd period 0 0 0 0 0 0 
NQC composition       
Moisture (%) 65.07±0.23 65.19±1.17 65.67±1.10 64.27±0.57 65.75±1.08 65.65±0.29 
Protein (%) 18.46±0.23 18.87±0.27 18.69±0.51 18.82±0.81 18.89±0.70 18.99±0.28 
Crude Lipid (%) 13.56±0.21 12.57±0.58 12.64±0.82 13.47±1.03 12.07±0.32 12.92±0.48 
Ash (%) 1.37±0.04 1.34±0.05 1.27±0.06 1.38±0.08 1.33±0.09 1.38±0.11 
       
 The present data are the real mean values for each parameter with their standard deviation (SD). Statistical analysis using linear mixed effect models estimates 
the expected mean values the above parameters with their 95% confidence intervals (by using 1500 random draws). These are shown in Figure 1. Parameters 
in italics were the ones analysed statistically. Data for the proximate composition of Norwegian quality cut (NQC) fillet samples are referred as means ± SD of 
4 pooled samples per diet (1 pool per tank). Data for the performance factors are referred as means ± SD of 4 replicate tanks.  Significant differences between 
the groups due to the use of different diets (P values < 0.1) are denoted by different letters (Modelled based statistical analysis).  
*Wt gain (Daily Weight gain) (g/fish/day) =Total wt of fish within treatment (g) × (Number of fish within treatment)-1× (Number of trial days)-1; **Feed intake 
= Amount of food ingested by fish per treatment (g); †Feed Conversion Ratio (FCR) = Feed intake (g) × Overall Weight gain (g); ‡Condition Factor (K) = Fish 
Weight (g) × Fish Length (cm)3).  
Diet abbreviations: MB, European commercial marine based diet (2011-12); VP, vegetable protein diet; VO, vegetable oil diet; VP/VO, vegetable 
protein/vegetable oil diet; MBABP, Non-EU commercial marine based diet with inclusion of animal-by-products (2011-12); MFABP, fish free animal-by-
product diet.  
  
Table 5  Effect of experimental diets on immunological and haematological responses of Atlantic salmon post-smolts. 
 
Haematological & Immune 
parameters 
MB MBABP     MFABP          VP       VO VP/VO 
Haematocrit (%) 47.9±5.3A 51.4±5.7BC 52.7±6.5B 50.9±3.7ABC    48.6±3.7AC 53.5±6.3B 
Leucocytes (× 107×ml-1) 10.3±4.0 10.2±2.9 10.2±2.7 11.7±3.7 10.4±3.9 8.3±1.9 
Lymphocytes (× 107×ml-1) 5.2±2.1 5.6±1.4 4.8±1.4 5.8±1.6 4.9±1.4 4.3±1.3 
Thrombocytes (× 107×ml-1) 4.4±1.7 4.1±1.7 4.8±1.6 5.3±1.9 4.9±2.8 3.6±1.4 
Granulocytes (× 107×ml-1) 0.6±0.4 0.4±0.2 0.5±0.3 0.6±0.3 0.5±0.5 0.5±0.2 
Monocytes (× 107×ml-1) 0.05±0.08 0.03±0.04 0.04±0.05 0.05±0.06 0.06±0.06 0.03±0.03 
Lysozyme activity (units × min-1× ml-1) 1259.8±252.1A 913.7±319.5B 794.7±372.2B 791.9±289.6B 912.4±185.1B 830.1±317.0B 
Plasma haemolytic activity (units SH50×ml-1) 928±298.2 954.6±139.1 1043.1±378.3 928.5±260.1 986.8±444.2 906.8±271.4 
HKMs respiratory burst (NBT) (O.D.610 for 105 
nuclei) 
0.40±0.15 0.53±0.26 0.37±0.18 0.36±0.22 0.40±0.21 0.36±0.22 
Stimulated HKMs respiratory burst (O.D.610 for 105 
nuclei) 
0.55±0.22 0.66±0.29 0.51±0.19 0.50±0.28 0.52±0.23 0.49±0.29 
Total plasma protein (mg×ml-1) 66.4±6.3 66.1±8.3 65.3±6.7 66.5±6.3 67.9±4.3 67.9±5.9 
Plasma antiprotease act. (Units TI75 × min-1× ml-1) 713.6±15.9A 665.4±66.0B 757.9±32.1C 740.2±12.0AC 701±57.3AB 727.5±28.2AC 
Total plasma IgM (mg×ml-1) 6.4±2.8 5.8±2.6 3.7±2.8 5.1±3.1 7.9±2.6 3.9±2.8 
       
The present data are the real mean values for each parameter with their standard deviation (SD). Statistical analysis using linear mixed effect models estimates 
the expected mean values the above parameters with their 95% confidence intervals (by using 1500 random draws). Selected models are shown in Figure 2. 
Values for immune responses are means ± SD from 8 pools of 3 fish per diet; for haematocrit values are means ± SD from 24 individual fish per diet; and for 
leucocyte and differential leucocyte counts values are means ± SD from 12 individual fish per diet. Significant differences between the groups due to the use of 
different diets (P values < 0.1) are denoted by different letters (Modelled based statistical analysis).  
Diet abbreviations: MB, European commercial marine based diet (2011-12); VP, vegetable protein diet; VO, vegetable oil diet; VP/VO, vegetable 
protein/vegetable oil diet; MBABP, Non-EU commercial marine based diet with inclusion of animal-by-products (2011-12); MFABP, fish free animal-by-
product diet. 
 
